D-0306-2021 Class III Terminated

Recalled by Edge Pharma, LLC — Colchester, VT

FDA drug recall D-0306-2021 was initiated by Edge Pharma, LLC on Feb 17, 2021 and is designated Class III. Reason for recall: Temperature Abuse; labeled with the incorrect room temperature (15-25 ¿C) storage conditions rather than the correct refrigerated (2 - 8 ¿C) storage conditions The recall status is terminated (terminated Jun 10, 2021). Affected quantity: 213 kits.

Recall details

Product Type
Drugs
Report Date
Mar 24, 2021
Initiation Date
Feb 17, 2021
Termination Date
Jun 10, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
213 kits

Product description

Methacholine Challenge 5-Syringe Test Kits, Sterile Inhalation Solution, Preservative Free, 3 mL per syringe, Edge Pharma, LLC, 856 Hercules Dr., Dolchester, VT 06448 NDC # 05446-1600-05

Reason for recall

Temperature Abuse; labeled with the incorrect room temperature (15-25 ¿C) storage conditions rather than the correct refrigerated (2 - 8 ¿C) storage conditions

Distribution pattern

Nationwide in the US

Code information

Lot # 12-2020-16@10, BUD 3-30-21 Lot # 11-2020-18@11, BUD 3-02-21

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0306-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0306-2021. Report a data issue: hello@regdatalab.com.